You are about to exit for another SJM country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Stay current on stock prices, investor resources and events.
today’s conversation on PULSE, the St. Jude Medical blog.
In all that we do, we remain singularly focused on innovation and partnerships that make a difference for those dealing with some of the world’s most costly and widespread diseases: patients and their families, health care professionals, hospitals and clinics, payers and the communities in which we work and live across the globe.
That is why each year we report on the previous year’s performance. We also share what makes our approach to disease-state management unique and recommit to our vision to transform the treatment of expensive epidemic diseases.
At St. Jude Medical, we take on some of the world’s biggest health care challenges. We are focused on transforming the treatment of expensive epidemic diseases where medical device innovation can save and improve lives and drive down the overall cost of care.
—Michael T. Rousseau, President and Chief Executive Officer
Take some time to review our latest annual and corporate sustainability reports to learn more about St. Jude Medical and the character, passion, imagination and distinct perspective we bring to challenging the status quo.
Read President and CEO Michael Rousseau’s 2015 letter to our shareholders and access our annual report.
Read about our initiatives to fulfill our mission and meet our responsibilities to the planet and its people in our corporate sustainability report.
Our infographic conveys some of the fundamental facts about St. Jude Medical and our unique vision.